annual net income:
$235.24M+$771.22M(+143.89%)Summary
- As of today (May 29, 2025), SRPT annual net profit is $235.24 million, with the most recent change of +$771.22 million (+143.89%) on December 31, 2024.
- During the last 3 years, SRPT annual net income has risen by +$654.02 million (+156.17%).
- SRPT annual net income is now at all-time high.
Performance
SRPT Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$447.51M-$606.56M(-381.36%)Summary
- As of today (May 29, 2025), SRPT quarterly net profit is -$447.51 million, with the most recent change of -$606.56 million (-381.36%) on March 1, 2025.
- Over the past year, SRPT quarterly net income has dropped by -$483.63 million (-1338.98%).
- SRPT quarterly net income is now -381.36% below its all-time high of $159.05 million, reached on December 31, 2024.
Performance
SRPT quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$248.39M-$483.63M(-205.59%)Summary
- As of today (May 29, 2025), SRPT TTM net profit is -$248.39 million, with the most recent change of -$483.63 million (-205.59%) on March 1, 2025.
- Over the past year, SRPT TTM net income has dropped by -$265.29 million (-1570.01%).
- SRPT TTM net income is now -205.59% below its all-time high of $235.24 million, reached on December 31, 2024.
Performance
SRPT TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SRPT Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +143.9% | -1339.0% | -1570.0% |
| 3 y3 years | +156.2% | -326.1% | +30.3% |
| 5 y5 years | +132.9% | -2458.4% | +62.1% |
SRPT Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +133.4% | -381.4% | +13.4% | -205.6% | +77.7% |
| 5 y | 5-year | at high | +132.9% | -381.4% | +13.4% | -205.6% | +77.7% |
| alltime | all time | at high | +132.9% | -381.4% | +13.4% | -205.6% | +77.7% |
SRPT Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$447.51M(-381.4%) | -$248.39M(-205.6%) |
| Dec 2024 | $235.24M(-143.9%) | $159.05M(+373.2%) | $235.24M(+93.1%) |
| Sep 2024 | - | $33.61M(+420.3%) | $121.84M(+157.6%) |
| Jun 2024 | - | $6.46M(-82.1%) | $47.30M(+179.9%) |
| Mar 2024 | - | $36.12M(-20.9%) | $16.90M(-103.2%) |
| Dec 2023 | -$535.98M(-23.8%) | $45.66M(-211.5%) | -$535.98M(-22.4%) |
| Sep 2023 | - | -$40.94M(+71.0%) | -$690.88M(-23.9%) |
| Jun 2023 | - | -$23.94M(-95.4%) | -$907.68M(-18.6%) |
| Mar 2023 | - | -$516.75M(+373.0%) | -$1.12B(+58.5%) |
| Dec 2022 | -$703.49M(+68.0%) | -$109.24M(-57.6%) | -$703.49M(-1.8%) |
| Sep 2022 | - | -$257.74M(+11.3%) | -$716.23M(+41.4%) |
| Jun 2022 | - | -$231.48M(+120.4%) | -$506.63M(+42.1%) |
| Mar 2022 | - | -$105.03M(-13.9%) | -$356.56M(-14.9%) |
| Dec 2021 | -$418.78M(-24.4%) | -$121.98M(+153.4%) | -$418.78M(-13.9%) |
| Sep 2021 | - | -$48.14M(-40.9%) | -$486.12M(-23.4%) |
| Jun 2021 | - | -$81.41M(-51.3%) | -$634.47M(-9.9%) |
| Mar 2021 | - | -$167.25M(-11.7%) | -$703.89M(+27.0%) |
| Dec 2020 | -$554.13M(-22.5%) | -$189.32M(-3.7%) | -$554.13M(-7.7%) |
| Sep 2020 | - | -$196.50M(+30.3%) | -$600.51M(+13.2%) |
| Jun 2020 | - | -$150.82M(+762.2%) | -$530.34M(-19.1%) |
| Mar 2020 | - | -$17.49M(-92.6%) | -$655.92M(-8.3%) |
| Dec 2019 | -$715.08M(+97.6%) | -$235.70M(+86.6%) | -$715.08M(+15.3%) |
| Sep 2019 | - | -$126.33M(-54.3%) | -$620.27M(+8.8%) |
| Jun 2019 | - | -$276.40M(+260.6%) | -$570.33M(+41.5%) |
| Mar 2019 | - | -$76.64M(-45.6%) | -$403.20M(+11.4%) |
| Dec 2018 | -$361.92M(+614.0%) | -$140.90M(+84.4%) | -$361.92M(+47.7%) |
| Sep 2018 | - | -$76.39M(-30.1%) | -$245.02M(+13.2%) |
| Jun 2018 | - | -$109.27M(+209.0%) | -$216.36M(+27.2%) |
| Mar 2018 | - | -$35.36M(+47.4%) | -$170.14M(+235.7%) |
| Dec 2017 | -$50.69M(-81.0%) | -$24.00M(-49.7%) | -$50.69M(-56.0%) |
| Sep 2017 | - | -$47.73M(-24.3%) | -$115.14M(-7.3%) |
| Jun 2017 | - | -$63.05M(-175.0%) | -$124.15M(+0.6%) |
| Mar 2017 | - | $84.09M(-195.1%) | -$123.41M(-53.8%) |
| Dec 2016 | -$267.26M(+21.5%) | -$88.45M(+55.9%) | -$267.26M(+9.8%) |
| Sep 2016 | - | -$56.74M(-8.9%) | -$243.49M(+2.0%) |
| Jun 2016 | - | -$62.30M(+4.2%) | -$238.69M(+9.4%) |
| Mar 2016 | - | -$59.77M(-7.6%) | -$218.24M(-0.8%) |
| Dec 2015 | -$220.03M(+62.0%) | -$64.68M(+24.5%) | -$220.03M(+10.1%) |
| Sep 2015 | - | -$51.94M(+24.1%) | -$199.76M(+12.8%) |
| Jun 2015 | - | -$41.85M(-32.0%) | -$177.05M(+4.7%) |
| Mar 2015 | - | -$61.56M(+38.6%) | -$169.07M(+24.5%) |
| Dec 2014 | -$135.79M(+21.3%) | -$44.42M(+52.0%) | -$135.79M(+35.5%) |
| Sep 2014 | - | -$29.23M(-13.7%) | -$100.19M(-11.3%) |
| Jun 2014 | - | -$33.87M(+19.8%) | -$113.00M(+15.1%) |
| Mar 2014 | - | -$28.27M(+220.6%) | -$98.17M(-12.3%) |
| Dec 2013 | -$111.98M(-7.7%) | -$8.82M(-79.0%) | -$111.98M(-32.2%) |
| Sep 2013 | - | -$42.03M(+120.6%) | -$165.23M(-4.4%) |
| Jun 2013 | - | -$19.05M(-54.7%) | -$172.76M(+18.6%) |
| Mar 2013 | - | -$42.08M(-32.2%) | -$145.67M(+20.1%) |
| Dec 2012 | -$121.29M(+5132.4%) | -$62.07M(+25.3%) | -$121.29M(+100.0%) |
| Sep 2012 | - | -$49.55M(-716.5%) | -$60.63M(+301.6%) |
| Jun 2012 | - | $8.04M(-145.4%) | -$15.10M(-30.9%) |
| Mar 2012 | - | -$17.70M(+1155.6%) | -$21.86M(+842.8%) |
| Dec 2011 | -$2.32M(-92.8%) | -$1.41M(-64.9%) | -$2.32M(-72.9%) |
| Sep 2011 | - | -$4.02M(-414.3%) | -$8.55M(-27.7%) |
| Jun 2011 | - | $1.28M(-30.2%) | -$11.82M(-60.3%) |
| Mar 2011 | - | $1.83M(-124.0%) | -$29.76M(-7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$32.18M(+27.9%) | -$7.64M(+4.8%) | -$32.18M(+53.2%) |
| Sep 2010 | - | -$7.29M(-56.2%) | -$21.01M(-3.7%) |
| Jun 2010 | - | -$16.66M(+2752.1%) | -$21.80M(-12.1%) |
| Mar 2010 | - | -$584.00K(-116.6%) | -$24.82M(-1.4%) |
| Dec 2009 | -$25.16M(+5.0%) | $3.52M(-143.6%) | -$25.16M(-15.6%) |
| Sep 2009 | - | -$8.09M(-58.9%) | -$29.83M(+7.4%) |
| Jun 2009 | - | -$19.67M(+2021.7%) | -$27.78M(+181.6%) |
| Mar 2009 | - | -$927.00K(-18.7%) | -$9.87M(-58.8%) |
| Dec 2008 | -$23.95M(-11.8%) | -$1.14M(-81.1%) | -$23.95M(-11.1%) |
| Sep 2008 | - | -$6.05M(+245.3%) | -$26.94M(-3.5%) |
| Jun 2008 | - | -$1.75M(-88.3%) | -$27.93M(-19.5%) |
| Mar 2008 | - | -$15.02M(+263.8%) | -$34.71M(+18.0%) |
| Dec 2007 | -$27.17M(-12.6%) | -$4.13M(-41.3%) | -$29.42M(-12.8%) |
| Sep 2007 | - | -$7.03M(-17.6%) | -$33.76M(+2.4%) |
| Jun 2007 | - | -$8.54M(-12.2%) | -$32.98M(+5.2%) |
| Mar 2007 | - | -$9.72M(+14.9%) | -$31.34M(+2.2%) |
| Dec 2006 | -$31.07M(+86.3%) | -$8.46M(+35.4%) | -$30.68M(+14.6%) |
| Sep 2006 | - | -$6.25M(-9.4%) | -$26.77M(+20.5%) |
| Jun 2006 | - | -$6.90M(-23.8%) | -$22.21M(+9.7%) |
| Mar 2006 | - | -$9.06M(+99.1%) | -$20.24M(+21.4%) |
| Dec 2005 | -$16.68M(-32.7%) | -$4.55M(+168.9%) | -$16.68M(-2.6%) |
| Sep 2005 | - | -$1.69M(-65.7%) | -$17.11M(-16.6%) |
| Jun 2005 | - | -$4.93M(-10.3%) | -$20.53M(-9.7%) |
| Mar 2005 | - | -$5.50M(+10.2%) | -$22.74M(-8.2%) |
| Dec 2004 | -$24.78M(+69.5%) | -$4.99M(-2.3%) | -$24.78M(+8.3%) |
| Sep 2004 | - | -$5.11M(-28.6%) | -$22.88M(+2.2%) |
| Jun 2004 | - | -$7.15M(-5.1%) | -$22.38M(+19.5%) |
| Mar 2004 | - | -$7.53M(+143.3%) | -$18.73M(+28.1%) |
| Dec 2003 | -$14.62M(-50.2%) | -$3.10M(-32.7%) | -$14.62M(-5.8%) |
| Sep 2003 | - | -$4.60M(+31.6%) | -$15.51M(-13.6%) |
| Jun 2003 | - | -$3.50M(+2.3%) | -$17.96M(-28.0%) |
| Mar 2003 | - | -$3.42M(-14.4%) | -$24.96M(-15.0%) |
| Dec 2002 | -$29.36M(+9.0%) | -$3.99M(-43.4%) | -$29.36M(-2.0%) |
| Sep 2002 | - | -$7.05M(-32.8%) | -$29.97M(-22.2%) |
| Jun 2002 | - | -$10.50M(+34.3%) | -$38.51M(+22.0%) |
| Mar 2002 | - | -$7.82M(+69.8%) | -$31.56M(+17.2%) |
| Dec 2001 | -$26.93M(+191.4%) | -$4.60M(-70.5%) | -$26.93M(+6.3%) |
| Sep 2001 | - | -$15.60M(+339.8%) | -$25.33M(+111.3%) |
| Jun 2001 | - | -$3.55M(+11.6%) | -$11.98M(+6.3%) |
| Mar 2001 | - | -$3.18M(+5.7%) | -$11.28M(+22.1%) |
| Dec 2000 | -$9.24M(+11.3%) | -$3.01M(+33.5%) | -$9.24M(+7.0%) |
| Sep 2000 | - | -$2.25M(-20.7%) | -$8.63M(+0.6%) |
| Jun 2000 | - | -$2.84M(+149.2%) | -$8.58M(+10.9%) |
| Mar 2000 | - | -$1.14M(-52.5%) | -$7.74M(-6.7%) |
| Dec 1999 | -$8.30M(-68.9%) | -$2.40M(+9.1%) | -$8.30M(0.0%) |
| Sep 1999 | - | -$2.20M(+10.0%) | -$8.30M(-69.7%) |
| Jun 1999 | - | -$2.00M(+17.6%) | -$27.40M(+1.1%) |
| Mar 1999 | - | -$1.70M(-29.2%) | -$27.10M(+1.1%) |
| Dec 1998 | -$26.70M(+641.7%) | -$2.40M(-88.7%) | -$26.80M(+6.3%) |
| Sep 1998 | - | -$21.30M(+1152.9%) | -$25.20M(+425.0%) |
| Jun 1998 | - | -$1.70M(+21.4%) | -$4.80M(+9.1%) |
| Mar 1998 | - | -$1.40M(+75.0%) | -$4.40M(+33.3%) |
| Dec 1997 | -$3.60M(+71.4%) | -$800.00K(-11.1%) | -$3.30M(+32.0%) |
| Sep 1997 | - | -$900.00K(-30.8%) | -$2.50M(+56.3%) |
| Jun 1997 | - | -$1.30M(+333.3%) | -$1.60M(+433.3%) |
| Mar 1997 | - | -$300.00K | -$300.00K |
| Dec 1996 | -$2.10M | - | - |
FAQ
- What is Sarepta Therapeutics annual net profit?
- What is the all time high annual net income for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual net income year-on-year change?
- What is Sarepta Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly net income year-on-year change?
- What is Sarepta Therapeutics TTM net profit?
- What is the all time high TTM net income for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM net income year-on-year change?
What is Sarepta Therapeutics annual net profit?
The current annual net income of SRPT is $235.24M
What is the all time high annual net income for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual net profit is $235.24M
What is Sarepta Therapeutics annual net income year-on-year change?
Over the past year, SRPT annual net profit has changed by +$771.22M (+143.89%)
What is Sarepta Therapeutics quarterly net profit?
The current quarterly net income of SRPT is -$447.51M
What is the all time high quarterly net income for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly net profit is $159.05M
What is Sarepta Therapeutics quarterly net income year-on-year change?
Over the past year, SRPT quarterly net profit has changed by -$483.63M (-1338.98%)
What is Sarepta Therapeutics TTM net profit?
The current TTM net income of SRPT is -$248.39M
What is the all time high TTM net income for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM net profit is $235.24M
What is Sarepta Therapeutics TTM net income year-on-year change?
Over the past year, SRPT TTM net profit has changed by -$265.29M (-1570.01%)